Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610618-25-000006
Filing Date
2025-01-07
Accepted
2025-01-07 18:38:27
Documents
1
Period of Report
2025-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736293101.html 4  
1 FORM 4 wk-form4_1736293101.xml 4 4511
  Complete submission text file 0001610618-25-000006.txt   6111
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108
Business Address
Resnick Joshua (Reporting) CIK: 0001690959 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 25516108